MULTIPLE MYELOMA PROGRESSION
Clinical trials for MULTIPLE MYELOMA PROGRESSION explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE MYELOMA PROGRESSION trials appear
Sign up with your email to follow new studies for MULTIPLE MYELOMA PROGRESSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy builds Cancer-Killing cells inside you – no lab needed
Disease control Recruiting nowThis early-stage study tests a new gene therapy called KLN-1010 for people with multiple myeloma that has returned or not responded to treatment. Instead of removing cells, modifying them in a lab, and putting them back, this therapy aims to create cancer-fighting CAR-T cells dir…
Matched conditions: MULTIPLE MYELOMA PROGRESSION
Phase: PHASE1 • Sponsor: Kelonia Therapeutics, Inc. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Simple blood test could catch myeloma years earlier in High-Risk groups
Diagnosis Recruiting nowThis study aims to find multiple myeloma at its earliest, precancerous stage (MGUS) in people at higher risk—Black adults and those with a family history of plasma cell disorders. By screening with a simple blood test, researchers hope to catch the disease before it causes seriou…
Matched conditions: MULTIPLE MYELOMA PROGRESSION
Sponsor: Wake Forest University Health Sciences • Aim: Diagnosis
Last updated May 14, 2026 12:05 UTC
-
Can early palliative care boost quality of life for blood cancer patients?
Symptom relief Recruiting nowThis study looks at whether adding early palliative care to usual treatment helps people with multiple myeloma or aggressive lymphoma feel better. About 144 patients and their caregivers will either get early palliative care or standard care alone. Researchers will track quality …
Matched conditions: MULTIPLE MYELOMA PROGRESSION
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated May 17, 2026 03:15 UTC